Trial intelligence / Profile preview

Induction Chemotherapy and Chemoradiation in Advanced Hypopharynx and Base of Tongue Cancer

NCT00002735Phase 2Terminated

Sponsor
SWOG Cancer Research Network
Start
Apr 1996
Primary completion
Apr 2004
Modality
Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Cisplatin micelle injection (HA132), fluorouracil in head and neck squamous cell carcinoma (HNSCC), sponsored by SWOG Cancer Research Network. Started Apr 1996; status: terminated.

02

Drugs

Cisplatin micelle injection (HA132)fluorouracil
03

Conditions

head and neck squamous cell carcinoma (HNSCC)

Beyond the preview

Go deeper on NCT00002735.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002735.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call